Epidemiology of peripheral arterial disease and critical limb ischemia in an insured national population.

[1]  F. Biancari.  Meta-analysis of the prevalence, incidence and natural history of critical limb ischemia. , 2013, The Journal of cardiovascular surgery.

[2]  C. O’Malley,et al.  Misclassification of incident conditions using claims data: impact of varying the period used to exclude pre-existing disease , 2013, BMC Medical Research Methodology.

[3]  V. Aboyans,et al.  Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association. , 2012, Circulation.

[4]  F. Hu,et al.  Trends in cardiovascular health metrics and associations with all-cause and CVD mortality among US adults. , 2012, JAMA.

[5]  A. Gomes,et al.  A call to action: women and peripheral artery disease: a scientific statement from the American Heart Association. , 2012, Circulation.

[6]  D. Jacobs,et al.  Trends in smoking among adults from 1980 to 2009: the Minnesota heart survey. , 2010, American journal of public health.

[7]  T. Henry,et al.  The Incidence and Health Economic Burden of Ischemic Amputation in Minnesota, 2005-2008 , 2011, Preventing chronic disease.

[8]  M. Schermerhorn,et al.  Trends in the national outcomes and costs for claudication and limb threatening ischemia: angioplasty vs bypass graft. , 2011, Journal of vascular surgery.

[9]  P. Verpillat,et al.  Prevalence, incidence, and outcomes of critical limb ischemia in the US Medicare population , 2011 .

[10]  N. Hevelone,et al.  Socioeconomic and hospital-related predictors of amputation for critical limb ischemia. , 2010, Journal of vascular surgery.

[11]  H. Birnbaum,et al.  Clinical outcomes and medical care costs among medicare beneficiaries receiving therapy for peripheral arterial disease. , 2010, Annals of vascular surgery.

[12]  B. Gray,et al.  Open versus endovascular intervention for critical limb ischemia: a population-based study. , 2010, Journal of the American College of Surgeons.

[13]  D. Etzioni,et al.  Patterns of treatment for peripheral arterial disease in the United States: 1996-2005. , 2009, Journal of vascular surgery.

[14]  R. Town,et al.  National health care costs of peripheral arterial disease in the Medicare population , 2008, Vascular medicine.

[15]  G. Fitzgerald,et al.  The adverse effects of race, insurance status, and low income on the rate of amputation in patients presenting with lower extremity ischemia. , 2007, Journal of vascular surgery.

[16]  John V. White,et al.  Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). , 2007, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[17]  B. Kasiske,et al.  Peripheral arterial disease and renal transplantation. , 2006, Journal of the American Society of Nephrology : JASN.

[18]  A. Moskowitz,et al.  Trends, complications, and mortality in peripheral vascular surgery. , 2006, Journal of vascular surgery.

[19]  W. Grochulski,et al.  Health Care Resources and Costs for Treating Peripheral Artery Disease in a Managed Care Population: Results From Analysis of Administrative Claims Data , 2005, Journal of managed care pharmacy : JMCP.

[20]  J. Forbes,et al.  Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial , 2005, The Lancet.

[21]  S. Gutnikov,et al.  Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study) , 2005, The Lancet.

[22]  C. Kalbaugh,et al.  Preoperative clinical factors predict postoperative functional outcomes after major lower limb amputation: An analysis of 553 consecutive patients , 2005 .

[23]  S. Beddhu,et al.  Surgical revascularization versus amputation for peripheral vascular disease in dialysis patients: a cohort study , 2005, BMC nephrology.

[24]  Elizabeth Selvin,et al.  Prevalence of and Risk Factors for Peripheral Arterial Disease in the United States: Results From the National Health and Nutrition Examination Survey, 1999–2000 , 2004, Circulation.

[25]  J. Regensteiner,et al.  Functional outcome in a contemporary series of major lower extremity amputations. , 2003, Journal of vascular surgery.

[26]  M. McDermott,et al.  Functional outcomes and quality of life in peripheral arterial disease: current status , 2003, Vascular medicine.

[27]  S. Muluk,et al.  Natural history of claudication: long-term serial follow-up study of 1244 claudicants. , 2001, Journal of vascular surgery.

[28]  J. Dormandy,et al.  Major amputations: clinical patterns and predictors. , 1999, Seminars in vascular surgery.

[29]  R. Hamman,et al.  Effect of diagnostic criteria on the prevalence of peripheral arterial disease. The San Luis Valley Diabetes Study. , 1995, Circulation.

[30]  M. Catalano,et al.  Epidemiology of critical limb ischaemia: north Italian data. , 1993, The European journal of medicine.

[31]  R. Prescott,et al.  Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. , 1991, International journal of epidemiology.

[32]  E. Barrett-Connor,et al.  TABLE 1 Prevalence of PAD by traditional assessment : intermittent claudication and pulse palpation % Claudication % Pulse abnormalities Rose Femoral Posterior Dorsalis n Rose , 2005 .